KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strategy (MSTR) Research & Development (2016 - 2025)

Historic Research & Development for Strategy (MSTR) over the last 17 years, with Q3 2025 value amounting to $22.6 million.

  • Strategy's Research & Development fell 3212.82% to $22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $96.8 million, marking a year-over-year decrease of 2128.13%. This contributed to the annual value of $118.5 million for FY2024, which is 169.58% down from last year.
  • Per Strategy's latest filing, its Research & Development stood at $22.6 million for Q3 2025, which was down 3212.82% from $24.1 million recorded in Q2 2025.
  • Strategy's 5-year Research & Development high stood at $33.5 million for Q1 2022, and its period low was $22.6 million during Q3 2025.
  • Its 5-year average for Research & Development is $29.2 million, with a median of $29.7 million in 2023.
  • Per our database at Business Quant, Strategy's Research & Development surged by 2372.27% in 2021 and then tumbled by 3212.82% in 2025.
  • Over the past 5 years, Strategy's Research & Development (Quarter) stood at $30.9 million in 2021, then grew by 2.4% to $31.6 million in 2022, then fell by 4.61% to $30.2 million in 2023, then fell by 14.81% to $25.7 million in 2024, then fell by 12.02% to $22.6 million in 2025.
  • Its Research & Development stands at $22.6 million for Q3 2025, versus $24.1 million for Q2 2025 and $24.4 million for Q1 2025.